CI · News · 20260805N

Business Portfolio Review

Cigna Group · 2026-08-05 · Importance 31 · Surprise 42

Third-party reporting says Cigna is conducting an ongoing review of its business portfolio. The review is discussed alongside uncertainty over the company’s pharmacy benefit management operations and regulatory pressure in the United States. The reports provide no transaction announcement, timeline, or quantified financial effect from potential portfolio changes.

Key facts

• David Cordani's strategic maneuvers included the acquisition of Express Scripts. source
• Under David Cordani's tenure Cigna was transformed into a $275 billion healthcare giant. source
• David Cordani served a 17-year tenure as Cigna CEO. source